Trials / Completed
CompletedNCT05275270
Role of Topical Oxytocin Gel in Post-Menopausal Women
Role of Topical Oxytocin Gel On Vaginal Atrophy, Psycho-sexual and Psychological Function and Metabolic and Inflammatory Parameters in Post-Menopausal Egyptian Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- Female
- Age
- 47 Years – 66 Years
- Healthy volunteers
- Accepted
Summary
Aim of the current study: To evaluate the effect of a14 day treatment period with local intravaginal application of an oxytocin-containing gel on vaginal atrophy, psychosexual and psychological/cognitive function, and metabolic, stress, and inflammatory parameters in Egyptian post-menopausal women
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | oxytocin gel | The active oxytocin gel (A) consisted of oxytocin dissolved in a gel-based on hypromellose with a pH of 3.8. 1 ml of gel contained 600 IU of oxytocin |
| OTHER | placebo gel | The placebo gel (B) consisted of the gel alone |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
- First posted
- 2022-03-11
- Last updated
- 2022-03-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05275270. Inclusion in this directory is not an endorsement.